Austria
Technoclone is a pioneer in producing diagnostic tests, equipment, and research products focusing on blood clotting. With a legacy dating back to 1987, the company stands at the forefront of Health Care and Medical Devices industries. Technoclone prides itself on its innovative approach, aiming to address the evolving complexity in the diagnosis of hematological and cardiovascular disorders. The company boasts a comprehensive product portfolio and is recognized as a global leader in the production of diagnostic tests, equipment, and research products within the field of blood clotting.
Their flagship product, the Ceveron 100 series, represents a significant advancement in the realm of coagulation analysis. This fully automated analyzer series caters to various assays including clotting, chromogenic, and turbidimetric, alongside thrombin generation and quenching technology. Notably, the development of the new high power LED quenching module positions the Ceveron s100 as a milestone in specialty haemostasis diagnostics.
Whilst not specifying their headquarter location or the details of their last investment and investors, Technoclone remains dedicated to pioneering the solutions for the diagnostic challenges of tomorrow, affirming their commitment to advancing the healthcare and medical devices domains.
